Safety Syringe Market Outlook from 2024 to 2034

[RahulFMI]

As per Future Market Insights (FMI) industry analysis, the Global Safety Syringe Market was valued at US$ 7,416.3 million in 2023. The market is anticipated to exhibit a CAGR of 4.5% from 2024 to 2034. It is projected to attain a valuation of US$ 12,054.3 million by 2034 from US$ 7,736.2 million in 2024.

Request Exclusive Sample Report: Safety Syringe Market Strategic Insights https://www.futuremarketinsights.com/reports/sample/rep-gb-18769

Notable technological developments in the safety syringe industry have created creative and efficient safety measures. To provide better protection and simplicity of use, manufacturers are producing a variety of safety syringes, including retractable, sheathing, and passive syringes. These technological developments have facilitated the expansion of the market.

Employee safety and well-being are becoming increasingly important to healthcare companies and institutions. Healthcare worker safety protocols are deemed complete with safety syringes since they lower the possibility of needlestick injuries. The need for safety syringes has surged due to the increased focus on the safety of healthcare workers.

Due to factors including population growth, aging populations, and the development of healthcare infrastructure, healthcare spending has been rising globally. Purchasing safety syringes account for a component of this expense, which is directed toward improving patient and healthcare worker safety. The market conditions for the safety syringes sector are good due to the increasing healthcare costs.

The market is growing due to rising awareness efforts and instructional programs about the value of safety syringes and the dangers of needlestick injuries. The use of safe syringes is on the rise due to aggressive awareness-raising campaigns by governments, healthcare organizations, and nonprofits, as well as training programs for medical staff.

Key Takeaways from the Market Study-

By product, the retractable segment is expected to rise at a CAGR of 4.1% over the forecast period.
By application, the subcutaneous segment held the leading market share of 65.7% in 2023.
By distribution channel, retail sales generated the dominant market share of 71.3% in 2023.
By end-users, the hospital segment is expected to surge at a CAGR of 2.8% from 2024 to 2034.
North America is considered the leading region, expanding at a CAGR of 2.6% by 2034.
"The rising focus on the prevention of needle stick injuries and increasing risk of bloodborne disease would help push the market for safety syringes over the forecast period," says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

Safety Syringe Market Research Report Coverage:

Attribute

Details

Estimated Market Size (2024)

US$ 7,736.2 million

Forecast Market Size (2034)

US$ 12,054.3 million

Projected Growth Rate (2024 to 2034)

4.5 %

Forecast Period

2024 to 2034

Historical Data Available for

2019 to 2023

Key Countries Covered

•  United States

•  Canada

•  Mexico

•  Brazil

•  Chile

•  the Rest of Latin America

•  China

•  Japan

•  South Korea

•  India

•  the Association of Southeast Asian Nations

•  Australia and New Zealand

•  the Rest of South Asia and Pacific

•  Germany

•  Italy

•  France

•  United Kingdom

•  Spain BENELUX

•  Nordic Countries

•  Rest of Western Europe

•  Russia

•  Hungary

•  Poland

•  Rest of Eastern Europe

•  Saudi Arabia

•  Türkiye

•  South Africa

•  Other African Union

•  Rest of Middle East and Africa

Key Segments Covered

By Product:

-Retractable

-Manual Retractable Safety Syringes

-Automatic Retractable Safety Syringes

-Non-retractable

-Sliding Needle Cover Syringes

- Sheathing Tube Syringes

- Hinged Needle Cover Syringes

By Application:

Subcutaneous

Intramuscular

By Distribution Channel:

Direct to Customer (DTC)

Retail Sales

Retail Pharmacies

Drug Stores

Online Pharmacies

By End-user:

Hospitals

Ambulatory Surgical Centers

Long-term Care Facilities

Specialty Clinics

Others

By Regions:

North America

Latin America

South Asia and Pacific

East Asia

Western Europe

Eastern Europe

Middle East and Africa

Key Companies Profiled


Becton, Dickinson and Company
AdvaCare Pharma
Cardinal Health Inc.
DMC Medical Ltd.
Duopross Meditech Corp.
Haiou Medical
Kendall Healthcare
Lifelong Meditech (Group)
 


Medicina (HMC Group)
Medline Industries
Nipro Corporation
Numedico
Nemera
Retractable Technologies, Inc.
Revolutions Medical Corporation
Smith's Medical, Inc. (ICU Medical, Inc.)
 


Sol-Millennium Medical Group
Terumo Corporation
UltiMed, Inc. (Ulticare)
Unilife Corporation
B. Braun Melsungen AG
Fresenius Kabi AG
West Pharmaceutical Services, Inc.
 

Report Coverage

Market Forecast, Competition Intelligence, Drivers, Restraints, Opportunities, Trends, Market Dynamics and Challenges, Strategic Growth Initiatives